Stockscreener 앱 받기
2.29
4.18%
-0.10
전일 마감가:
$2.39
열려 있는:
$2.39
하루 거래량:
14,303
Relative Volume:
0.16
시가총액:
$85.63M
수익:
$68.72M
순이익/손실:
$-24.01M
주가수익비율:
-3.6372
EPS:
-0.6296
순현금흐름:
$-24.95M
1주 성능:
-5.37%
1개월 성능:
+1.33%
6개월 성능:
+16.84%
1년 성능:
-10.20%
1일 변동 폭
$2.23
$2.39
1주일 범위
$2.23
$2.55
52주 변동 폭
$1.21
$3.08
Edap Tms S A Adr Stock (EDAP) Company Profile
EDAP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EDAP
Edap Tms S A Adr
|
2.29 | 89.37M | 68.72M | -24.01M | -24.95M | -0.6296 |
|
MCK
Mckesson Corporation
|
772.54 | 94.76B | 377.60B | 3.35B | 5.67B | 25.08 |
|
COR
Cencora Inc
|
312.53 | 59.73B | 316.65B | 1.91B | 1.14B | 9.72 |
|
CAH
Cardinal Health Inc
|
156.96 | 36.72B | 222.58B | 1.57B | 1.85B | 6.45 |
|
HSIC
Henry Schein Inc
|
66.37 | 8.01B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.73 | 980.32M | 2.22M | -5.63M | -1.68M | -0.24 |
Edap Tms S A Adr Stock (EDAP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-15 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2025-04-04 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-11-01 | 개시 | Jefferies | Buy |
| 2021-04-28 | 개시 | Piper Sandler | Overweight |
| 2020-04-15 | 개시 | B. Riley FBR | Buy |
| 2014-07-28 | 다운그레이드 | Northland Capital | Outperform → Market Perform |
| 2014-06-16 | 개시 | H.C. Wainwright | Buy |
| 2013-03-05 | 개시 | Northland Capital | Outperform |
| 2010-11-18 | 재확인 | Morgan Joseph | Buy |
| 2009-08-20 | 재확인 | Roth Capital | Hold |
| 2008-11-24 | 재확인 | Roth Capital | Hold |
| 2008-03-26 | 재확인 | Roth Capital | Hold |
| 2007-11-09 | 재확인 | Roth Capital | Hold |
| 2007-03-16 | 재확인 | Roth Capital | Hold |
| 2007-01-24 | 재확인 | Roth Capital | Hold |
모두보기
Edap Tms S A Adr 주식(EDAP)의 최신 뉴스
Will EDAP TMS S.A. Depositary Receipt stock outperform value stocksMarket Sentiment Report & Fast Entry High Yield Stock Tips - newser.com
Focal One® HIFU Receives Prestigious Innovation Award - GlobeNewswire Inc.
EDAP TMS Focuses on Robotic HIFU Leadership in Prostate Cancer - MSN
France approves reimbursement for EDAP’s prostate cancer treatment - Investing.com
Market reaction to NDLS’s recent news2025 Trade Ideas & Real-Time Stock Price Movement Reports - Newser
Earnings call transcript: EDAP TMS Q2 2025 reports revenue growth, stock rises - Investing.com
EDAP secures €36 million credit facility from European Investment Bank By Investing.com - Investing.com
How hedge fund analytics apply to BP P.L.C. ADRhedged stock2025 Trading Recap & Free Daily Entry Point Trade Alerts - Newser
Will Suburban Propane Partners L.P. Limited Partnership benefit from macro trendsDay Trade & Low Risk Investment Opportunities - Newser
Tools to monitor EDAP TMS S.A. Depositary Receipt recovery probabilityFree Risk Adjusted Technical Entry Plan - Newser
EDAP TMS at Jefferies Conference: Strategic Shift to HIFU Therapy - Investing.com
EDAP TMS at Jefferies Conference: Strategic Shift to HIFU Therapy By Investing.com - Investing.com India
edap tms sa announces shareholder meeting for june 2025 By Investing.com - Investing.com India
edap tms sa announces shareholder meeting for june 2025 - Investing.com
H.C. Wainwright cuts EDAP stock price target to $14 By Investing.com - Investing.com South Africa
H.C. Wainwright cuts EDAP stock price target to $14 - Investing.com
Focal ablation shows promise in prostate cancer trial By Investing.com - Investing.com South Africa
Jefferies cuts EDAP TMS stock rating, slashes target to $2 - Investing.com
Piper Sandler cuts EDAP stock price target to $4.50, keeps rating - Investing.com India
H.C. Wainwright maintains $19 target on EDAP TMS stock - Investing.com India
Earnings call transcript: EDAP TMS Q4 2024 sees revenue growth, stock surges - Investing.com
EDAP's Avenda Deal For AI-Assisted Cancer Care Likely To Drive Stock - Barchart.com
EDAP shares hold as analyst reiterates $19 target on growth - Investing.com
Biotech & Pharma News, Stocks, FDA Decision, Clinical Trials - RTTNews
Perkins Capital Raises Exposure in EDAP TMS - Insider Monkey
Edap Tms S A Adr (EDAP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.38%
2.56%
자본화:
|
볼륨(24시간):